BAP1 and renal cell carcinoma: Notably, rates of BAP1 mutations in patients with RCC and ACKD were low at 1.6% relative to patients without ACKD in the ORIEN cohort and historical controls (estimated prevalence of approximately 15% in clear cell RCC and papillary RCC) [31,32].